Ramipril Capsule
Product Images NDC 68071-3971

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 68071-3971). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3971 3 (2))

Pdp (68071 3971 3 (2))
This is a pharmaceutical product label for Ramipril 10mg capsules, containing 30 capsules in total. The label includes important information such as the National Drug Code (NDC), lot number, product number, storage instructions, and a warning to keep the product out of reach of children. It also indicates that this product is only available with a prescription.*
FDA Label Image

Figure 1 (Ramipril Fig1)

Figure 1 (Ramipril Fig1)
This information appears to be a data table showing the proportions of patients for different categories. The table includes percentages such as 0.2, 0.1, 0.1, and 0.0. The table also mentions the medication "Ramipril" with "Days of Follow-up" indicated as 1500 days. Additionally, it appears to have a statistical result with P=0.0001, which could be related to the patient data presented.*
FDA Label Image

Figure 2 (Ramipril Fig2)

Figure 2 (Ramipril Fig2)
This text provides information about different health conditions and characteristics of a group of patients, including cardiovascular disease, diabetes, age, sex, hypertension, history of coronary artery disease, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria. It also lists the number of patients in different categories and presents the incidence of a composite outcome in the placebo group. There is data on the relative risk in the Ramipril group with a 95% confidence interval.*
FDA Label Image

Chemical Structure (Ramipril Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.